R Cleymaet, T Vermassen, R Coopman… - International Journal of …, 2022 - mdpi.com
Salivary gland malignancies (SGMs) account for less than 5% of new diagnoses in head and neck tumors. If feasible, surgery is the preferred treatment modality. Nevertheless, some …
Salivary gland tumors are highly variable in clinical presentation and histology. The World Health Organization (WHO) classifies 22 types of malignant and 11 types of benign tumors …
J Ling, L Zhang, Y Wang, A Chang… - Phytotherapy …, 2023 - Wiley Online Library
Cisplatin (DDP) resistance is a bottleneck in the treatment of head and neck cancer (HNC), leading to poor prognosis. Fisetin, a dietary flavonoid, has low toxicity and high antitumor …
H Du, K Zhu - Technology and Health Care, 2024 - content.iospress.com
BACKGROUND: Laryngeal cancer is a malignant tumor that originates from the mucous membrane of the larynx. Currently, the specific involvement mechanism of copper death in …
Y Xie - BIO Web of Conferences, 2024 - bio-conferences.org
Cancer, a pervasive challenge of global health, necessitates advanced technologies for diagnosticsand therapies. Ovarian, breast, and colon cancers, notable for their complexity …